The Brazilian Journal of Otorhinolaryngology aims to provide timely information for physicians and scientists focused on otorhinolaryngology and head and neck disorders, including contemporary, ethical, clinically relevant information in:
- General otolaryngology;
- Head and neck surgery;
- Respiratory sleep disorders;
- Allergy/rhinology;
- Otology/neurotology;
- Laryngology/broncho-esophagology;
- Pediatric otolaryngology;
- Cranio-facial surgery;
- Skull base surgery;
- Head and neck oncology;
- Phoniatrics;
- Upper airway related diseases;
- Facial plastics and reconstructive surgery.
The journal is the official peer-reviewed open access scientific publication of the Brazilian Association of Otorhinolaryngology and Cervicofacial Surgery (ABORL-CCF).
All articles will be published under the CC-BY license (Creative Commons Attribution 4.0 International) with copyright owned by the ABORL-CCF.
Please note that articles submitted as of May 1, 2022, which are accepted for publication will be subject to a fee (Article Publishing Charge, APC) payment by the author or research funder to cover the costs associated with publication.
Indexed in:
MEDLINE/PubMed, Scopus, Web of Science/SCIE, DOAJ, Lilacs, SciELO, Qualis A3
See moreFollow us:
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2022
SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.
See moreSNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.
See moreArticles in press are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info
- •
Using databases to analyze IL-1 and related genes for their relevance in HNSCC.
- •
We found IL18RAP and SIGIRR are highly expressed in HPV+ tumors.
- •
IL18RAP, IL36A and SIGIRR were found to be prognostic protective factors.
- •
IL-1A, IL1RAP, IL18RAP and SIGIRR affect the prognosis by CD8+ T-cell infiltration.
- •
Despite being rare, death from the progression of papillary thyroid cancer occurs.
- •
Factors associated with this outcome are not completely understood.
- •
Ki-67 expression >11% was associated with death from the disease.
- •
NOSE-Perf scale quantifies symptoms resulting from nasal septal perforation.
- •
The Portuguese version of the NOSE-perf scale showed internal consistency.
- •
The NOSE-Perf scale translation showed good reliability parameters.
- •
The proposed instrument is valid for measuring nasal septal perforation symptoms.
- •
Frozen biopsy isolated is not a reliable tool for guiding surgical decisions when it comes negative.
- •
Frozen biopsy is reliable for malignant results.
- •
Larger biopsy fragments are associated with a more reliable diagnosis.
- •
ESP treatment with rhIFN-α2b is effective due to elimination of HPV.
- •
The introduction of rhIFN-α2b accelerated the resolution of postoperative reactions.
- •
The introduction of rhIFN-α2b promoted the healing of the nasal mucosa after surgical removal of the ESP.
- •
Three-months olfactory training is effective to treat the COVID-19-related anosmia.
- •
Daily oral vitamin A did not lead to better results in improving anosmia.
- •
The intervention time was important in the final olfactory status of the patients.
- Call for papers
- Instructions for authors
- Submit an article
- Ethics in publishing
- Open Access
- Language Editing services